Evidence map›Paper›PMID 23946240›Full record

ArticleJournal of biomedical materials research. Part A2014

Effects of SiO2, SrO, MgO, and ZnO dopants in tricalcium phosphates on osteoblastic Runx2 expression.

Gary A Fielding, Will Smoot, Susmita Bose

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of materials chemistry. B · 2023
    Article
  4. Article
  5. In vivo biocompatibility of SrO and MgO doped brushite cements.Journal of biomedical materials research. Part B, Applied biomaterials · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of MgO, ZnO, SrO, and SiOMaterials science & engineering. C, Materials for biological applications · 2019
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gary A FieldingW. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, Washington, 99164-2920.
Will Smoot
Susmita Bose
Washington State University · US

Funding

Resorbable Calcium Phosphate Ceramics for Bone Graft.R01EB007351 · NIBIB · WASHINGTON STATE UNIVERSITY · PI BOSE, SUSMITA · 2008 to 2011
$1.4M
NIBIB NIH HHS R01 EB007351NIBIB NIH HHS R01-EB-007351
6 · The paper itself

Abstract

Calcium phosphate materials share a compositional similarity to natural bone, which makes them excellent for use in orthopedic applications. Although these materials are osteoconductive, they lack strong osteoinductive capabilities and recent research has focused on the addition of biologics and pharmacologics with varying successes. In this study, trace elements that have been proven to play important roles in bone health and bone formation were incorporated into β-tricalcium phosphate compacts in their oxide forms (SiO2, ZnO, SrO, and MgO). Cell material interactions were characterized using human fetal preosteoblastic cells. An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay was used to evaluate cellular proliferation. Cellular differentiation was evaluated using an enzymatic colorimetric alkaline phosphatase assay as well as immunohistochemistry for Runt-related transcription factor 2 (Runx2) expression. Results prove ZnO and MgO to be effective mitogenic factors and SiO2, ZnO, and SrO to be capable of inducing rapid cellular differentiation. MgO was found to have little effect on the modulation of osteoblastic differentiation, likely due to more aggressive inherent cellular regulation of Mg(2+). In addition to the results from the study, a signaling mechanism is proposed as to the action of the dopants for further consideration.

Indexed as

Calcium PhosphatesCore Binding Factor Alpha 1 SubunitHumansMagnesium OxideOsteoblastsSilicon DioxideStrontiumZinc OxideCalcium PhosphatesCore Binding Factor Alpha 1 SubunitMagnesium OxideRUNX2 protein, humanSilicon DioxideStrontiumtricalcium phosphateZinc Oxidebone tissue engineeringcalcium phosphatesmagnesiumsiliconstrontiumzinc

Identifiers

PMID23946240
PMCPMC3979499
OpenAlexW1880782688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.